12-Month Lobbying Summary - Organization

Innovative Medicines Canada (Medicaments novateurs Canada) / Bettina Hamelin, President and CEO

Registration Summary

Currently active - Last Updated: 2025-10-27

Who is lobbying?

Innovative Medicines Canada (Medicaments novateurs Canada) (Address & business activities)

Bettina Hamelin, President and CEO

Government Funding

Did Innovative Medicines Canada (Medicaments novateurs Canada) receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

Innovative Medicines Canada (Medicaments novateurs Canada) is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

Innovative Medicines Canada (Medicaments novateurs Canada) does not have any affiliates that could have a direct interest in the outcome of the lobbying activities

Other Affiliates

The activities of Innovative Medicines Canada (Medicaments novateurs Canada) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Innovative Medicines Canada (Medicaments novateurs Canada):

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocate for the adoption of innovative payer agreements at the pan-Canadian level that would incorporate real world evidence	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Advocate for workload capacity building and the acceleration of the work of the pan-Canadian Pharmaceutical Alliance which is an intergovernmental collaboration currently chaired by BC	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Budget 2025 preparation and submission discussion.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
Discussion highlighting the contribution of IMC membership to health outcomes and economic sustainability in British Columbia, and advocating for provincial government policy initiatives and investment decisions (e.g., R&D commercialization incentives, infrastructure support) to support the life sciences sector as a driver of long-term economic growth in the province	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Science and Technology
Discussion on the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Engage with the BC government to advocate for greater access to innovative medicines and vaccines for British Columbians, supportive policies to attract research and development investment, and greater collaboration to build a stronger life sciences sector and a more sustainable health system.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
PharmaCare budget, pharmaceutical listings and the Pharmaceutical Care Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Subject matter details in previous versions

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Introductory meeting, update on life sciences strategy, life sciences sector value to BC in health and economic recovery.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health
Introductory meeting – we spoke about IMC and our members value to BC in health and economic recovery.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity Decision by the Executive Council or a member of the Executive Council to transfer from the Crown for consideration all or part of, or any interest in or asset of, any business, enterprise or institution that provides goods or services to the Crown, a Provincial entity or the public Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly	Health
life sciences sector	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Budget 2024 preparation and submission discussion.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Finances and Budgets, Health

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Children and Family Development
Finance
Fraser Health Authority
Health
Innovate BC
Interior Health Authority
Jobs and Economic Growth
Member(s) of the BC Legislative Assembly
Providence Health Care Society
Provincial Health Services Authority
Simon Fraser University
University of British Columbia
University of Victoria
Vancouver Coastal Health Authority

Ministries/Provincial Entities in previous versions
- Jobs, Economic Development and Innovation

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Charles Brown
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No